Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule for Patients With Mild to Moderate COVID-19

NCT05249777 is registered in ClinicalTrials.gov with Sao Thai Duong Joint Stock Company as lead sponsor.

NCT NCT05249777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05249777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule for Patients With Mild to Moderate COVID-19
Lead sponsor
Sao Thai Duong Joint Stock Company
Phase
Phase 3
Overall status
Completed
Start date
January 6, 2022
Completion date
September 10, 2022
Enrollment
573 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19